Scott Andrew McDonald

Scott Andrew McDonald

Auto-generated profile, based on publicly available information

Scott Andrew McDonald

Statistics and Epidemiology Unit, RTI International, Research Triangle Park, North Carolina

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
EJErik A. Jensen
Erik A. Jensen
KDKevin Dysart
Kevin Dysart
MGMarie Gantz
Marie Gantz
SMScott McDonald
Scott McDonald
NBNicolas A. Bamat
Nicolas A. Bamat
SDSara B. DeMauro
Sara B. DeMauro
Rationale: Current diagnostic criteria for bronchopulmonary dysplasia rely heavily on the level and duration of oxygen therapy, do not reflect contemporary neonatal care, and do not adequately predict childhood morbidity. Objectives: To determine which of 18 prespecified, revised definitions of bronchopulmonary dysplasia that variably define disease severity according to the level of respiratory support and supplemental oxygen administered at 36 weeks’ postmenstrual age best predicts death or serious respiratory morbidity through 18–26 months’ corrected age. Methods: We assessed infants born at less than 32 weeks of gestation between 2011 and 2015 at 18 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Measurements and Main Results: Of 2,677 infants, 683 (26%) died or developed serious respiratory morbidity. The diagnostic criteria that best predicted this outcome defined bronchopulmonary dysplasia according to treatment with the following support at 36 weeks’ postmenstrual age, regardless of prior or current oxygen therapy: no bronchopulmonary dysplasia, no support (n = 773); grade 1, nasal cannula ≤2 L/min (n = 1,038); grade 2, nasal cannula >2 L/min or noninvasive positive airway pressure (n = 617); and grade 3, invasive mechanical ventilation (n = 249). These criteria correctly predicted death or serious respiratory morbidity in 81% of study infants. Rates of this outcome increased stepwise from 10% among infants without bronchopulmonary dysplasia to 77% among those with grade 3 disease. A similar gradient (33–79%) was observed for death or neurodevelopmental impairment. Conclusions: The definition of bronchopulmonary dysplasia that best predicted early childhood morbidity categorized disease severity according to the mode of respiratory support administered at 36 weeks’ postmenstrual age, regardless of supplemental oxygen use.

1 January 2006 in Pediatrics
Verified
Journal Article
Closed access
PDF file
DBDaniel K. Benjamin
Daniel K. Benjamin
BSBarbara J. Stoll
Barbara J. Stoll
AFAvory A. Fanaroff
Avory A. Fanaroff
SMScott A. McDonald
Scott A. McDonald
WOWilliam Oh
William Oh
ONon behalf of the National Institute of Child Health and Human Development Neonatal Research Network
on behalf of the National Institute of Child Health and Human Development Neonatal Research Network
BACKGROUND. Neonatal candidiasis is associated with substantial morbidity and mortality rates. Neurodevelopmental follow-up data for a large multicenter cohort have not been reported.METHODS. Data were collected prospectively for neonates born at 1 day after initiation of antifungal therapy), compared with infants whose catheters were removed or replaced promptly.CONCLUSIONS. Blood cultures were negative for approximately one half of the infants with Candida meningitis. Persistent candidiasis was common. Delayed catheter removal was associated with increased death and NDI rates.

1 February 2006 in Pediatrics
Verified
Journal Article
Closed access
PDF file
RGRonnie Guillet
Ronnie Guillet
BSBarbara J. Stoll
Barbara J. Stoll
CCC. Michael Cotten
C. Michael Cotten
MGMarie Gantz
Marie Gantz
SMScott McDonald
Scott McDonald
FNfor members of the National Institute of Child Health and Human Development Neonatal Research Network
for members of the National Institute of Child Health and Human Development Neonatal Research Network
OBJECTIVE. We sought to determine if an association exists between the use of histamine-2 receptor (H2) blockers and the incidence of necrotizing enterocolitis (NEC) in infants of 401 to 1500 g in birth weight. STUDY DESIGN. Data from the National Institute of Child Health and Human Development Neonatal Research Network very low birth weight (401–1500 g) registry from September 1998 to December 2001 were analyzed. The relation between the diagnosis of NEC (Bell stage II or greater) and antecedent H2-blocker treatment was determined by using case-control methodology. Conditional logistic regression was implemented, controlling for gender, site of birth (outborn versus inborn), Apgar score of <7 at 5 minutes, and postnatal steroids. RESULTS. Of 11072 infants who survived for at least 12 hours, 787 (7.1%) developed NEC (11.5% of infants 401–750 g, 9.1% of infants 751–1000 g, 6.0% of infants 1001–1250 g, and 3.9% of infants 1251–1500 g). Antecedent H2-blocker use was associated with an increased incidence of NEC (P < .0001). CONCLUSIONS. H2-blocker therapy was associated with higher rates of NEC, which is in agreement with a previous randomized trial of acidification of infant feeds that resulted in a decreased incidence of NEC. In combination, these data support the hypothesis that gastric pH level may be a factor in the pathogenesis of NEC.

1 August 2006 in Pediatrics
Verified
Journal Article
Closed access
PDF file
CCCharles Michael Cotten
Charles Michael Cotten
SMScott McDonald
Scott McDonald
BSBarbara Stoll
Barbara Stoll
RGRonald N. Goldberg
Ronald N. Goldberg
KPKenneth Poole
Kenneth Poole
ONon behalf of the National Institute for Child Health and Human Development Neonatal Research Network
on behalf of the National Institute for Child Health and Human Development Neonatal Research Network
OBJECTIVES. Previous studies have shown that incidence of invasive candidiasis varies substantially among centers, and previous use of broad-spectrum antibiotics is a risk factor for candidiasis in extremely low birth-weight infants. Differences in center practices, such as antibiotic strategies and the effects of these strategies on center incidence of candidiasis, are not reflected in assessments of an individual's risk of candidiasis. We evaluated the relationship between empirical antibiotic practices for extremely low birth-weight infants and center incidence of candidiasis. METHODS. We studied a cohort of extremely low birth-weight infants who survived ≥72 hours and were admitted to 1 of 12 tertiary centers between 1998 and 2001. Multivariable logistic regression was used to validate previous broad-spectrum antibiotics use as a risk factor for subsequent candidiasis in individual infants. We calculated correlation coefficients to assess the relationship between center incidence of candidiasis with antibiotic practice patterns. RESULTS. There were 3702 infants from 12 centers included, and 284 (7.7%) developed invasive candidiasis. Broad-spectrum antibiotics use was associated with candidiasis for individual infants. Center candidiasis incidence ranged from 2.4% to 20.4%. Center incidence of candidiasis was correlated with average broad-spectrum antibiotics use per infant and average use of broad-spectrum antibiotics with negative cultures per infant. CONCLUSIONS. Center incidences of invasive candidiasis differ substantially, and antibiotic practice differences are possible contributors to center variation in candidiasis risk.

24 December 2014 in JAMA
Verified
Journal Article
Open access
PDF file
SSSeetha Shankaran
Seetha Shankaran
ALAbbot R. Laptook
Abbot R. Laptook
APAthina Pappas
Athina Pappas
SMScott. A. McDonald
Scott. A. McDonald
ADAbhik Das
Abhik Das
Birju A. ShahBirju A. Shah
Birju A. Shah
Hypoxic ischemic encephalopathy due to acute perinatal asphyxia is an important cause of childhood neurodevelopmental deficits among infants who were born at full-term. Five randomized clinical trials of induced hypothermia at 33.0°C to 34.0°C for 72 hours have demonstrated a decrease in death or disability up to 24 months of age.1-7 This neuroprotection continues to childhood8-10; however, the rate of death or disability in the cooled group remains high (range, 44%-55%).1-7

1 April 2009 in Pediatrics
Verified
Journal Article
Closed access
PDF file
NANamasivayam Ambalavanan
Namasivayam Ambalavanan
WCWaldemar A. Carlo
Waldemar A. Carlo
CDCarl T. D'Angio
Carl T. D'Angio
SMScott A. McDonald
Scott A. McDonald
ADAbhik Das
Abhik Das
FNfor the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
OBJECTIVE. The goal was to develop multivariate logistic regression models for the outcome of bronchopulmonary dysplasia and/or death at postmenstrual age of 36 weeks by using clinical and cytokine data from the first 28 days.METHODS. For 1067 extremely low birth weight infants in the Neonatal Research Network of the National Institute of Child Health and Human Development, levels of 25 cytokines were measured in blood collected within 4 hours after birth and on days 3, 7, 14, and 21. Stepwise regression analyses using peak levels of the 25 cytokines and 15 clinical variables identified variables associated with bronchopulmonary dysplasia/death. Multivariate logistic regression analysis was performed for bronchopulmonary dysplasia/death by using variables selected through stepwise regression. Similar analyses were performed by using average cytokine values from days 0 to 21, days 0 to 3, and days 14 to 21.RESULTS. Of 1062 infants with available data, 606 infants developed bronchopulmonary dysplasia or died. On the basis of results from all models combined, bronchopulmonary dysplasia/death was associated with higher concentrations of interleukin 1β, 6, 8, and 10 and interferon γ and lower concentrations of interleukin 17, regulated on activation, normal T cell expressed and secreted, and tumor necrosis factor β. Compared with models with only clinical variables, the addition of cytokine data improved predictive ability by a statistically significant but clinically modest magnitude.CONCLUSIONS. The overall cytokine pattern suggests that bronchopulmonary dysplasia/death may be associated with impairment in the transition from the innate immune response mediated by neutrophils to the adaptive immune response mediated by T lymphocytes.